Prenatal Lead Exposure, Genetic Factors, and Cognitive Developmental Delay.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
02 10 2023
02 10 2023
Historique:
medline:
27
10
2023
pubmed:
23
10
2023
entrez:
23
10
2023
Statut:
epublish
Résumé
Although the effects of lead (Pb) exposure on neurocognition in children have been confirmed, the individual associations of prenatal Pb exposure and its interaction with genetic factors on cognitive developmental delay (CDD) in children remain unclear. To investigate the association of prenatal Pb exposure and its interaction with genetic factors with CDD risk. Women in Wuhan, China, who had an expected delivery date between March 2014 and December 2017, were recruited for this prospective cohort study. Children were assessed for cognitive development at approximately 2 years of age (March 2016 to December 2019). Maternal venous blood, cord blood, and venous blood from children were collected in a longitudinal follow-up. Data analysis was performed from March 2022 to February 2023. Prenatal Pb exposure, and genetic risk for cognitive ability evaluated by polygenic risk score constructed with 58 genetic variations. Cognitive developmental delay of children aged approximately 2 years was assessed using the Chinese revision of the Bayley Scale of Infant Development. A series of multivariable logistic regressions was estimated to determine associations between prenatal Pb exposure and CDD among children with various genetic backgrounds, adjusting for confounding variables. This analysis included 2361 eligible mother-child pairs (1240 boys [52.5%] and 1121 girls [47.5%]; mean [SD] ages of mothers and children, 28.9 [3.6] years and 24.8 [1.0] months, respectively), with 292 children (12.4%) having CDD. Higher maternal Pb levels were significantly associated with increased risk of CDD (highest vs lowest tertile: odds ratio, 1.55; 95% CI, 1.13-2.13), adjusting for demographic confounders. The association of CDD with maternal Pb levels was more evident among children with higher genetic risk (highest vs lowest tertile: odds ratio, 2.59; 95% CI, 1.48-4.55), adjusting for demographic confounders. In this cohort study, prenatal Pb exposure was associated with an increased risk of CDD in children, especially in those with a high genetic risk. These findings suggest that prenatal Pb exposure and genetic background may jointly contribute to an increased risk of CDD for children and indicate the possibility for an integrated strategy to assess CDD risk and improve children's cognitive ability.
Identifiants
pubmed: 37870833
pii: 2810983
doi: 10.1001/jamanetworkopen.2023.39108
pmc: PMC10594149
doi:
Substances chimiques
Lead
2P299V784P
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2339108Commentaires et corrections
Type : CommentIn
Références
Neurotoxicology. 2014 Sep;44:1-7
pubmed: 24704588
Environ Res. 2020 Oct;189:109844
pubmed: 32678746
N Engl J Med. 1988 Aug 25;319(8):468-75
pubmed: 3405253
J Occup Environ Med. 2010 Nov;52(11):1106-11
pubmed: 21063188
Int J Hyg Environ Health. 2014 Apr-May;217(4-5):528-37
pubmed: 24262290
Psychol Med. 2022 May;52(7):1356-1364
pubmed: 32924895
Environ Res. 2022 Mar;204(Pt B):112049
pubmed: 34520749
J Neuroinflammation. 2017 Apr 7;14(1):80
pubmed: 28388927
J Natl Cancer Inst. 2020 Sep 1;112(9):893-901
pubmed: 31899501
Environ Health Perspect. 2021 Mar;129(3):37003
pubmed: 33730866
Environ Health Perspect. 1990 Nov;89:101-5
pubmed: 2088735
Occup Environ Med. 2011 Mar;68(3):231-4
pubmed: 20798002
Sci Total Environ. 2023 Jul 15;882:163383
pubmed: 37068684
Environ Health Perspect. 2014 Mar;122(3):310-6
pubmed: 24441767
Environ Health Perspect. 2009 Jan;117(1):26-31
pubmed: 19165383
JAMA Pediatr. 2021 Jun 1;175(6):577-585
pubmed: 33749704
J Neurobiol. 2003 Jan;54(1):4-45
pubmed: 12486697
Am J Hum Genet. 2019 Jan 3;104(1):21-34
pubmed: 30554720
Environ Res. 2018 Aug;165:1-10
pubmed: 29655037
Environ Health Perspect. 2002 Mar;110(3):263-8
pubmed: 11882477
Reprod Toxicol. 2014 Aug;47:21-6
pubmed: 24878230
Neurotoxicology. 2017 Sep;62:162-169
pubmed: 28687448
Front Genet. 2018 Mar 16;9:89
pubmed: 29662502
Front Public Health. 2022 Jul 01;10:922563
pubmed: 35844875
Proc Natl Acad Sci U S A. 2014 Sep 23;111(38):13790-4
pubmed: 25201988
Mol Psychiatry. 2015 Feb;20(2):183-92
pubmed: 25644384
Neurotoxicol Teratol. 2000 Nov-Dec;22(6):811-8
pubmed: 11120386
Eur J Epidemiol. 2005;20(7):575-9
pubmed: 16119429
Nat Genet. 2013 Apr;45(4):400-5, 405e1-3
pubmed: 23455638
Neurotoxicol Teratol. 1989 Mar-Apr;11(2):95-104
pubmed: 2733658
Neurotoxicology. 2013 Mar;35:15-22
pubmed: 23220728
Mol Psychiatry. 2016 Jun;21(6):758-67
pubmed: 27046643
Ann N Y Acad Sci. 2008 Oct;1140:184-9
pubmed: 18991916
J Public Health Manag Pract. 2019 Jan/Feb;25 Suppl 1, Lead Poisoning Prevention:S13-S22
pubmed: 30507765
Environ Health Perspect. 2006 Nov;114(11):1730-5
pubmed: 17107860
Environ Int. 2020 Feb;135:105379
pubmed: 31841805
Neurosci Biobehav Rev. 2017 Sep;80:382-393
pubmed: 28642071
Br J Psychiatry. 2021 Sep;219(3):507-514
pubmed: 33583444
Am J Ind Med. 1998 May;33(5):430-8
pubmed: 9557166